Digital Quantitative Detection for Heterogeneous Protein and mRNA Expression Patterns in Circulating Tumor Cells
Authors:
Open Access
- 18 November 2024
- journal article
- research article
- Published by Wiley in Advanced Science
- Vol. 12 (2) , e2410120
Abstract
Hepatocellular carcinoma (HCC) circulating tumor cells (CTCs) exhibit significant phenotypic heterogeneity and diverse gene expression profiles due to epithelial‐mesenchymal transition (EMT). However, current detection methods lack the capacity for simultaneous quantification of multidimensional biomarkers, impeding a comprehensive understanding of tumor biology and dynamic changes. Here, the CTC Digital Simultaneous Cross‐dimensional Output and Unified Tracking (d‐SCOUT) technology is introduced, which enables simultaneous quantification and detailed interpretation of HCC transcriptional and phenotypic biomarkers. Based on self‐developed multi‐real‐time digital PCR (MRT‐dPCR) and algorithms, d‐SCOUT allows for the unified quantification of Asialoglycoprotein Receptor (ASGPR), Glypican‐3 (GPC‐3), and Epithelial Cell Adhesion Molecule (EpCAM) proteins, as well as Programmed Death Ligand 1 (PD‐L1), GPC‐3, and EpCAM mRNA in HCC CTCs, with good sensitivity (LOD of 3.2 CTCs per mL of blood) and reproducibility (mean %CV = 1.80–6.05%). In a study of 99 clinical samples, molecular signatures derived from HCC CTCs demonstrated strong diagnostic potential (AUC = 0.950, sensitivity = 90.6%, specificity = 87.5%). Importantly, by integrating machine learning, d‐SCOUT allows clustering of CTC characteristics at the mRNA and protein levels, mapping normalized heterogeneous 2D molecular profiles to assess HCC metastatic risk. Dynamic digital tracking of eight HCC patients undergoing different treatments visually illustrated the therapeutic effects, validating this technology's capability to quantify the treatment efficacy. CTC d‐SCOUT enhances understanding of tumor biology and HCC management.Keywords
Funding Information
- National Key Research and Development Program of China (2023YFC2413201)
- National Natural Science Foundation of China (Nos.52275581,82372142,82327802)
This publication has 68 references indexed in Scilit:
- The development of real-time digital PCR technology using an improved data classification methodBiosensors and Bioelectronics, 2022
- Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular CarcinomaHepatology, 2021
- Dual‐Isolation and Profiling of Circulating Tumor Cells and Cancer Exosomes from Blood Samples with Melanoma Using Immunoaffinity‐Based Microfluidic InterfacesAdvanced Science, 2020
- Quantification of Protein Secretion from Circulating Tumor Cells in Microfluidic ChambersAdvanced Science, 2020
- Single Extracellular Vesicle Protein Analysis Using Immuno‐Droplet Digital Polymerase Chain Reaction AmplificationAdvanced Biosystems, 2020
- Bioinspired Engineering of a Multivalent Aptamer‐Functionalized Nanointerface to Enhance the Capture and Release of Circulating Tumor CellsAngewandte Chemie International Edition, 2018
- Detection of CTC Clusters and a Dedifferentiated RNA‐Expression Survival Signature in Prostate CancerAdvanced Science, 2018
- AASLD guidelines for the treatment of hepatocellular carcinomaHepatology, 2017
- Rational Design of Materials Interface for Efficient Capture of Circulating Tumor CellsAdvanced Science, 2015
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011